Rob Carlson

Managing Director

2022 - Current

Managing Director

2014

Bioeconomy Capital (BeC) invests in early stage companies with the goal of accelerating the biotechnology revolution. Based on our startup operational expertise, product development experience, and globally recognized strategic analysis, we have developed a blueprint for building and deploying technological capabilities that will become critical infrastructure of the 21st century economy. This proprietary blueprint is the distillation of the fund managers' five decades of combined experience in synthetic biology and other engineering fields and cannot be readily duplicated. Prior investments include Zymergen, Riffyn, Synthace, RoosterBio, Arzeda, Bellwether Bio, and Lumen Biosciences.

Affiliate Professor

2018

Member Board Of Directors

2013

Member Board Of Directors

2017

Principal

2005 - 2023

Biodesic is a biological engineering, consulting, and design firm in Seattle and San Francisco. We provide technologies and knowledge to organizations building the future, including design and analysis services for hardware, software, and wetware. We specialize in developing strategy and policy in the context of rapid technological and economic change.

Research Fellow

1997 - 2022

Member, Board of Directors

2012 - 2019

Member, Forum on Synthetic Biology

2013 - 2017

Member, Board of Directors

2013 - 2016